Spondyloarthritis: How JAK inhibitor and TNF inhibitor drugs are helping in SpA

Speciality: Orthopedics


Speaker:

Dr. Jyotsna Oak | MD (Medicine) Consultant, Internal Medicine & Rheumatology

Dr. Shashank Akerkar | MD FACR Consultant Rheumatologist

Dr. Sourabh Malviya | MD FACR, Senior Consultant and Head Rheumatologist

Description:

A warm welcome to all the medical professionals in this interesting session on use of JAK inhibitor and TNF inhibitor drugs in spondyloarthritis. We have Dr. Jyotsna Oak, Dr. Shashank Akerkar and Dr. Sourabh Malviya to lead the session.

Spondyloarthritis is a type of arthritis where the spine is affected and, in some cases, the joints of the arms and legs are also affected. It can also involve the skin, intestines and eyes. The primary symptom observed in most patients is low back pain, mostly axial spondyloarthritis. 

It is thought that spondyloarthritis develops through the interaction of genetic and environmental factors. Further, spondyloarthropathies (SpA) is recognised as autoimmune disease as it is strongly associated with HLA-B27, a gene variant that controls immune responses. 

Therefore, listen to the webinar, grab the knowledge that is shared and follow HiDoc for more such interesting webinar sessions.
 


See More Webinars @ Hidoc Webinars




Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Having dense breasts is linked to cancer, but advice about breast density can depend on where you live

2.

Subcutaneous Cancer Immunotherapies Provide New Options for Physicians and Patients

3.

Frontline Decisions in Transplant-Ineligible Multiple Myeloma: Evaluating Quadruplet Therapy

4.

Smoldering Myeloma: The Treatment Issue Is Getting Trickier

5.

Blinatumomab May Improve Survival in High-Risk Adult B-ALL


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot